ニュースSamumed, LLC hired Darrin M. Beaupre as Chief Medical Officer, Oncology on Dec 1st '20.Samumed, LLC, a clinical-stage biotechnology company pioneering therapeutics based on RNA alternative splicing for major diseases, announced today that Dr. Darrin M. Beaupre will join the company as its Chief Medical Officer, Oncology.
ニュースSamumed, LLC hires Michael White as chief scientific officer.Michael White has been named chief scientific officer of Samumed, joining the company from his most recent position as vice president and chief scientific officer at Pfizer.
ニュースSamumed, LLC received financing of $438M in private equity funding on Aug 1st '19.Private equity is also investing in anti-aging and longevity R&D as Samumed has acquired $438 million in private equity funding in August from an undisclosed investor, this comes after amassing $326 million in venture capital investments since 2013.
